Vendor profile Research · US · —

Tianjin Eleli Technology Development

B
Composite 7.2 / 10

Last updated 2026-10-05. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
5.8
Fair
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
Retatrutide
8.1B+
7.6 16 — — — — view
GHK-Cu
7.8B+
7.3 6 — — — — view
Tirzepatide
7.1B
6.3 7 — — — — view
BPC-157
6.3C
5.3 6 — — — — view
Tesamorelin
5.8C
4.7 4 — — — — view
TB-500
4.9D
3.6 3 — — — — view
Ipamorelin
—
— 0 — — — — view
PT-141
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Tianjin Eleli Technology Development against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.